Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.56
Delayed Data
As of Aug 18
 -0.09 / -2.47%
Today’s Change
3.18
Today|||52-Week Range
10.98
-17.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-38.8M-50.0M-32.6M-57.7M
 
 
 
 
 
Depreciation489.0K512.0K613.0K642.0K
 
 
 
 
 
Total Other Cash Flow278.0K1.8M2.8M24.6M
 
 
 
 
 
Funds From Operations-38.0M-47.6M-29.1M-39.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.6M743.0K-273.0K-2.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-36.3M-48.4M-28.9M-36.8M
 
 
 
 
 
 
InvestingIncrease In Investments-70.8M-62.4M-61.6M-92.3M
 
 
 
 
 
Decrease In Investments68.3M71.9M86.0M71.4M
 
 
 
 
 
Capital Expenditures-252.0K-380.0K-771.0K-147.0K
 
 
 
 
 
Other Investing - Sources0.00104.0K0.000.00
 
 
Net Cash Flow Investing-2.7M9.2M23.7M-21.0M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.00--0.00--
Long Term Borrowings0.000.00--0.00--
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale26.1M40.4M22.6M43.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00225.0K
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing26.1M40.4M22.6M43.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-13.0M1.2M17.4M-14.1M